Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
ocugen宣佈歐洲藥品管理局授予Ocu410St修飾基因療法候選藥物孤兒藥品認定，用於治療包括斑馬魚疾病在內的Abca4相關視網膜病變
